Public health guidance on active case finding of communicable diseases in prison settings
This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.
Guidance in brief: Prevention and control of blood-borne viruses in prison settings
This guidance is intended for policymakers responsible for the planning and delivery of healthcare services in the national or sub-national custodial system and all professionals responsible for the health and well-being of people in prison, including community-based service providers and those facilitating continuity of care in the community.
Public health guidance on prevention and control of blood-borne viruses in prison settings
This document provides EU/EEA Member States with evidence-based scientific advice on available options, when planning and implementing prevention and control interventions for blood-borne viruses in prison settings.
Programmatic management of latent tuberculosis infection in the European Union
Programmatic management of latent tuberculosis infection (LTBI) is a key component of the global tuberculosis (TB) elimination strategy. This document provides evidence-based guidance for the implementation of programmatic management of LTBI in the European Union and European Economic Area (EU/EEA).
Systematic review on the diagnosis, treatment, care and prevention of tuberculosis in prison settings
The objective of this report is to systematically review data on the diagnosis, treatment, care and prevention of tuberculosis in prison settings, with a focus on the countries of the European Union and the European Economic Area.
Public health guidance on investigation and control of tuberculosis incidents affecting children in congregate settings
This report aims to bring the different components of generic outbreak management and tuberculosis specific policies and guidelines together, to develop a more comprehensive package of guidance to capture the elements that are specific for TB incidents affecting children in congregate settings.
Public health guidance on use of interferon-gamma release assays in support of TB diagnosis
This report sets out the evidence on IGRAs and their use in the diagnosis of latent and active tuberculosis.After reviewing all available evidence, the expert panel concluded that ‘IGRAs should not replace the standard diagnostic methods for diagnosing active TB.’
Risk assessment guidelines for diseases transmitted on aircraft (RAGIDA) - Part 2: Operational guidelines for assisting the evaluation of risk for transmission by disease
Technical guidance on risk assessment guidelines for diseases transmitted on aircraft (RAGIDA). Part 2: Operational guidelines - Second edition
In the closed cabin environment of modern airplanes, passengers are frequently exposed to various infectious diseases.
Risk assessment guidelines for infectious diseases transmitted on aircraft
In the closed cabin environment of modern airplanes, passengers are frequently exposed to various infectious diseases. This report looks at 12 infectious diseases and, by systematically evaluating literature on on-board transmission, attempts to assess the risk of infection via air circulation in airplanes.
These guidelines are complemented by operational guidelines in relation to tuberculosis, new emerging airborne diseases (e.g. SARS) and meningococcal infections.